Bias In Biotech Funding Has Blocked Companies Led By Women

In Economy On

Sangeeta Bhatia, a superstar of engineering and medicine, was working on a new biotechnology start-up company when she got a piece of friendly advice from an investor who had backed her previous company.

He said Bhatia, a tenured Massachusetts Institute of Technology professor, should bring along a male graduate student when she pitched the idea to venture capitalists. Sinking millions of dollars into a new idea that could transform medicine was a very personal decision, and he said it was important the investors feel comfortable, she recalled.

“As you talk to [female] colleagues in the world, they all kind of nod their head. ‘I’ve been told that,’” Bhatia said. “It’s sort of like: Note to self.”

Women have made significant gains in the sciences during the past few decades, but men continue to dominate leadership of the biotech industry — where science and business collide to turn ivory tower insights into medicines and biomedical technologies that can change the world. It’s a disparity hidden in plain sight, from the predominantly male chief executives of biotech companies to, as Bloomberg News reported, a party at the biggest dealmaking event of the year that featured models in tiny dresses as cocktail waitresses.

Read full article

You may also read!

The Secrets of ‘Cognitive Super-Agers’

One of my greatest pleasures during the Covid-19 shutdowns


Is Education No Longer the ‘Great Equalizer’?

There is an ongoing debate over what kind of


Even the terrorist threat to the United States is now partisan

Hours after he announced his objection to forming a


Mobile Sliding Menu